Profusa Presents Positive US-Study Clinical Results at Leipzig Interventional Course (LINC) 2026
Profusa, Inc. (PFSA)
Company Research
Source: GlobeNewswire
Study conducted at US sites evaluates LumeeTM in peripheral artery disease (PAD) patients BERKELEY, Calif, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: PFSA), a commercial stage digital health company pioneering a next-generation technology platform enabling the continuous monitoring of an individual’s biochemistry, announces the presentation of positive US-study clinical trial results at Leipzig Interventional Course in Leipgzig, Germany on Wednesday, January 28, 2026. The study, conducted at the University of California San Francisco, San Francisco VA Medical Center, and San Francisco General Hospital, showed Lumee oxygen tissue monitoring is a safe and effective method for long term monitoring of peripheral artery disease (PAD) patients. The data also demonstrated strong correlation with traditional transcutaneous partial pressure of oxygen (tcpO2). The presentation, titled, “Monitoring Tissue Oxygen Dynamics with a Novel Implantable H
Show less
Read more
Impact Snapshot
Event Time:
PFSA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFSA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFSA alerts
High impacting Profusa, Inc. news events
Weekly update
A roundup of the hottest topics
PFSA
News
- Profusa Announces 1-for-75 Reverse Stock SplitGlobeNewswire
- Profusa Launches Lumee™ Tissue Oxygen Healthcare Research Offerings, Initiating First Commercial RevenueGlobeNewswire
- Profusa Adds Leading Greek Vascular Surgeon to Customer Base [Yahoo! Finance]Yahoo! Finance
- Profusa Adds Leading Greek Vascular Surgeon to Customer BaseGlobeNewswire
- Profusa Bolsters European Commercial Network with New French Distributor, MedSell [Yahoo! Finance]Yahoo! Finance